Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Identification of Stage-related and Severity-Related Biomarkers and Exploration of Immune Landscape for Dengue by Comprehensive Analyses

Version 1 : Received: 7 December 2021 / Approved: 13 December 2021 / Online: 13 December 2021 (17:07:08 CET)

How to cite: Xiong, N.; Sun, Q. Identification of Stage-related and Severity-Related Biomarkers and Exploration of Immune Landscape for Dengue by Comprehensive Analyses. Preprints 2021, 2021120217. https://doi.org/10.20944/preprints202112.0217.v1 Xiong, N.; Sun, Q. Identification of Stage-related and Severity-Related Biomarkers and Exploration of Immune Landscape for Dengue by Comprehensive Analyses. Preprints 2021, 2021120217. https://doi.org/10.20944/preprints202112.0217.v1

Abstract

At present, there are still no specific therapeutic drugs and appropriate vaccines for Dengue. Therefore, it is very important to explore distinct clinical diagnostic indicators. In this study, we combined differentially expressed genes (DEGs) analysis and weighted co-expression network analysis (WGCNA) to screen a stable and robust biomarker which can be used to distinguish three clinical stages of Dengue and severity of Dengue. CD38 can distinguish excellently Early Acute, Late Acute, Convalescent stages for Dengue patients, and ZNF595 can discriminate DHF from DF in whole acute stages. We also found that three clinical stages can be discriminated based on the fractions of Plasma cells, activated memory CD4+ T cells, and Monocytes. In different clinical stages different immune cells function positively. Negative inhibition of viral replication based on Gene Ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and Gene set enrichment analysis (GSEA), up-regulated autophagy genes and impairing immune system are potential reasons resulting in dengue hemorrhagic fever (DHF).

Keywords

DH、DHF、CD38、ZNF595 and Autophagy

Subject

Medicine and Pharmacology, Epidemiology and Infectious Diseases

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.